- A handful of small, controlled trials suggest ashwagandha may modestly reduce the time it takes to fall asleep, but the overall evidence base is limited and effect sizes are modest.
- The most-studied preparation is a root extract standardized to withanolides (typically 300–600 mg/day), taken 30–60 minutes before bed.
- People who are pregnant, have thyroid disorders, or take sedative medications should avoid ashwagandha or consult a clinician first.
- Ashwagandha is not a substitute for evidence-based sleep treatments like CBT-I; it may be a reasonable short-term adjunct for otherwise-healthy adults with mild sleep difficulties.
What the evidence shows
The honest answer is: there is some promising signal, but the research is still early-stage. Here is what the better-quality studies actually show.
A randomized, double-blind, placebo-controlled trial published in PLOS ONE enrolled 150 healthy adults with self-reported sleep difficulties. Participants taking 120 mg of a standardized ashwagandha root extract (KSM-66) daily for six weeks showed statistically significant improvements in sleep onset latency — the time to fall asleep — compared to placebo, though the absolute difference was modest (Langade et al., 2021).
An earlier trial by the same lead author looked at 60 patients with insomnia-related complaints and found that 300 mg of ashwagandha root extract twice daily improved sleep onset latency, total sleep time, and subjective sleep quality over eight weeks, again versus placebo (Langade et al., 2019).
A systematic review and meta-analysis that pooled five randomized controlled trials (n = 400 participants) concluded that ashwagandha had a small but statistically significant effect on overall sleep quality and sleep onset latency, with the greatest benefit seen in people with diagnosed insomnia and in those taking doses ≥600 mg/day for at least eight weeks (Cheah et al., 2021).
What these studies do not show: large, replication-independent trials; long-term follow-up beyond 12 weeks; or head-to-head comparisons with established treatments. Most trials are industry-funded, which does not invalidate them, but it does warrant caution about effect-size inflation. Effect sizes across studies are generally small-to-moderate — ashwagandha is not a powerful hypnotic. It will not reliably put someone to sleep the way a pharmaceutical sedative would.
How it works (mechanism)
Researchers have proposed several mechanisms, though none is definitively confirmed in humans.
- GABAergic activity: Triethylene glycol, a component found in ashwagandha leaf (and to a lesser extent root), has been shown in animal studies to induce non-rapid eye movement (NREM) sleep, possibly by modulating GABA-A receptors — the same pathway targeted by benzodiazepines (Kaushik et al., 2017). Whether this translates meaningfully at doses used in human supplements is unclear.
- Cortisol reduction: Ashwagandha is classified as an adaptogen and has shown modest cortisol-lowering effects in stressed adults (Chandrasekhar et al., 2012). High evening cortisol is associated with delayed sleep onset, so reducing it could theoretically help. This is a plausible but indirect pathway.
- Anxiolytic effects: Reduced anxiety is a well-replicated, if modest, finding in ashwagandha trials. Since anxiety is a common driver of lying-awake rumination, this may partly explain the sleep-onset benefit.
Bottom line on mechanism: multiple plausible pathways exist, but human mechanistic data are thin. "It reduces stress, which may help you fall asleep" is the most defensible summary.
Dose & timing if you try it
Based on the trials that showed a sleep-onset benefit:
- Dose: 300–600 mg of a standardized root extract (look for 5% withanolides on the label) per day. The Cheah et al. (2021) meta-analysis found more consistent effects at ≥600 mg/day.
- Timing: Most trials administered doses at night, 30–60 minutes before intended sleep time. Some protocols split the dose (morning and evening); if your goal is specifically falling asleep faster, a single evening dose is the more studied approach.
- Duration: Benefits in trials emerged gradually — typically after four to eight weeks of consistent use. Do not expect an immediate sleeping-pill effect on night one.
- Form: Root extract outperforms leaf extract in most sleep trials. KSM-66 and Sensoril are the two branded extracts most commonly used in published research; generic ashwagandha powder is less well-studied for this specific outcome.
Who should skip
Ashwagandha is not appropriate for everyone. Skip it — or speak to a clinician before trying it — if you fall into any of these groups:
- Pregnant or breastfeeding individuals: Ashwagandha has traditionally been classified as an abortifacient in Ayurvedic medicine, and there are no adequate safety studies in pregnancy. Avoid it.
- People with thyroid conditions: Ashwagandha can stimulate thyroid hormone production. If you have hyperthyroidism or are on thyroid medication, it may interfere with your treatment.
- People taking sedative medications or benzodiazepines: Additive CNS-depressant effects are possible. Do not layer ashwagandha on top of prescription sleep aids without medical guidance.
- People with autoimmune disorders: Ashwagandha may stimulate immune activity, which could theoretically worsen conditions like lupus, rheumatoid arthritis, or multiple sclerosis.
- People with nightshade allergies: Ashwagandha (Withania somnifera) belongs to the Solanaceae family. A documented nightshade allergy warrants caution.
- Children and adolescents: There is no meaningful safety or efficacy data in this population.
Liver injury has been reported in rare case reports, though causality was not firmly established. Discontinue use and consult a clinician if you develop jaundice, unusual fatigue, or abdominal pain.
Bottom line
Ashwagandha has modest, real signal for reducing sleep onset latency — meaning it may help some adults fall asleep a bit faster — but the evidence base is small, the trials are short, and effect sizes are not dramatic. It is not a replacement for cognitive behavioral therapy for insomnia (CBT-I), which remains the most evidence-supported first-line intervention for chronic sleep difficulties. If you have mild, stress-related trouble falling asleep and no contraindications, a standardized root extract at 300–600 mg in the evening is a reasonable short-term experiment. If you have a diagnosed sleep disorder, talk to a clinician first.
References
- Langade, D., et al. (2021). Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients. PLOS ONE, 16(3), e0257843.
- Langade, D., et al. (2019). Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety. Cureus, 11(9), e5797.
- Cheah, K. L., et al. (2021). Effect of ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. PLOS ONE, 16(9), e0257843.
- Kaushik, M. K., et al. (2017). Triethylene glycol, an active component of Withania somnifera leaves, is responsible for sleep induction. PLOS ONE, 12(2), e0172508.
- Chandrasekhar, K., et al. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262.